Lactase Market Size, Share, and Growth Forecast, 2026 - 2033

The global lactase market size is likely to be valued at US$334.5 million in 2026 and is expected to reach US$499.6 million by 2033, growing at a CAGR of 5.9% during the forecast period from 2026 to 2033, expanding as rising consumer awareness of lactose intolerance and digestive wellness drives demand for lactose-free dairy products and specialized enzyme solutions.

The growing popularity of functional dairy beverages, high-protein products, and lactose-free milk is a major driver accelerating the adoption of high-efficiency lactase enzymes. Manufacturers are increasingly focusing on enzyme formulations that provide consistent hydrolysis, processing stability, and improved sensory outcomes across diverse dairy applications.

Driver - Growth in Functional Dairy Beverages Is Increasing Demand for High-Efficiency Lactase Enzymes

The rapid growth of functional dairy beverages is reshaping demand patterns and increasing the need for high-efficiency lactase enzymes. As consumers increasingly prefer protein-fortified shakes, probiotic beverages, and digestive-friendly dairy products, manufacturers are focusing on lactose-free formulations that offer improved taste, smoother textures, and consistent sweetness profiles.

High-performance lactase enzymes support faster and more efficient lactose hydrolysis, helping manufacturers reduce processing time while developing premium dairy beverages that cater to health-conscious consumers seeking convenience and digestive comfort. The growing popularity of ready-to-drink functional dairy products is also driving demand for advanced enzyme solutions that can maintain consistent performance during cold processing and throughout extended shelf-life periods. This trend is encouraging enzyme suppliers to develop faster-acting, high-purity lactase variants optimized for diverse beverage formulations, processing conditions, and large-scale production requirements.

Restraints- Variability in Enzyme Activity under Different Processing Conditions

A key challenge in the lactase market is the inconsistent performance of enzymes under varying processing conditions, including fluctuations in temperature, pH, and product composition. Such variability can affect hydrolysis efficiency, resulting in uneven lactose reduction, inconsistent sweetness levels, and a higher risk of products failing to meet quality specifications.

Manufacturers of lactose-free milk, yogurt, and functional dairy beverages often need to adjust enzyme dosage and processing parameters to achieve consistent results. Lactase formulations that perform effectively at low temperatures may demonstrate reduced efficiency in high-solids or compositionally complex applications, creating additional formulation and production challenges. These limitations can increase operational complexity and production costs while making it more difficult to maintain uniform taste, texture, and product quality.

Furthermore, variability in enzyme performance can extend product development timelines, as manufacturers may need to conduct additional pilot trials and compatibility testing before scaling production. The resulting uncertainty can limit processing flexibility and remains a significant barrier to the efficient large-scale production of lactose-free dairy products.

Opportunity - Growing Demand for Lactose-Free Infant Nutrition Presents High-Value B2B Enzyme Partnerships

The growing demand for lactose-free and low-lactose infant nutrition is creating significant opportunities for lactase enzyme producers. As awareness of lactose intolerance and digestive sensitivities among infants increases, infant formula manufacturers are seeking high-performance lactase solutions that enable predictable lactose hydrolysis while maintaining product quality, taste, and nutritional integrity across complex milk-based formulations.

This trend is encouraging closer collaboration between enzyme specialists and infant nutrition manufacturers to develop customized solutions that meet stringent requirements for safety, purity, stability, and regulatory compliance. Companies offering advanced lactase technologies, including precision-fermentation-derived enzymes and highly stable liquid formulations, can support the development of specialized infant nutrition products and establish long-term partnerships with formula manufacturers.

As consumer demand for specialized and digestive-friendly infant nutrition continues to expand, enzyme suppliers with validated product performance, strong technical expertise, and co-development capabilities are well positioned to capture premium growth opportunities in the global pediatric nutrition market.

Form Insights

Liquid lactase is anticipated to hold 47.2% of market share, driven by its ease of application, rapid dispersion, and suitability for large-scale dairy processing operations. The liquid format enables manufacturers to achieve efficient lactose hydrolysis while simplifying enzyme dosing and integration into existing production processes. It is widely used in the production of lactose-free milk, flavored dairy beverages, yogurt, and other liquid dairy products. For example, dairy processors producing lactose-free UHT milk and ready-to-drink dairy beverages can use liquid lactase to support efficient enzymatic treatment before or during processing. Its compatibility with automated processing systems and continuous production lines further strengthens its adoption among large dairy manufacturers. As demand for convenient lactose-free dairy products expands, liquid lactase is expected to maintain a strong market position.

Dry lactase segment is expected to emerge as the fastest-growing segment during the forecast period. Its longer shelf life, storage stability, and ease of transportation make it increasingly attractive for powdered dairy products, nutritional formulations, and manufacturing facilities operating across extended supply chains. Growing demand for shelf-stable enzyme solutions is expected to support the expansion of this segment.

Product Type Insights

Yeast-derived lactase is anticipated to hold a 54.9% of market share, supported by its established use in dairy processing and its effectiveness in hydrolyzing lactose across a range of milk-based applications. These enzymes are widely used in the production of lactose-free milk, yogurt, ice cream, cheese, and other dairy products where consistent lactose reduction and reliable processing performance are essential. For instance, yeast-derived lactase is particularly relevant for conventional dairy applications requiring controlled hydrolysis and consistent product quality. Its established commercial availability and familiarity among dairy processors continue to support its dominant position.

Bacterial-derived lactase is emerging as the fastest-growing product type due to its adaptability across broader pH and temperature conditions. Its ability to perform effectively in challenging processing environments makes it increasingly suitable for flavored milk, fermented dairy beverages, ready-to-drink coffees, and high-protein dairy formulations. As manufacturers focus on improving processing efficiency and expanding innovative lactose-free product portfolios, demand for bacterial-derived lactase is expected to grow rapidly during the forecast period.

North America Lactase Market Trends

North America is anticipated to account for a 38.4% of market share. Growth in the region is being supported by strong consumer demand for lactose-free dairy products, functional beverages, and high-protein nutrition. Dairy manufacturers are increasingly seeking advanced lactase enzymes that can deliver consistent hydrolysis across different temperature profiles while preserving the taste, texture, and nutritional characteristics of the final product. The expanding use of lactase in ultra-filtered milk, ready-to-drink beverages, flavored dairy products, and cultured foods is also strengthening demand for specialized enzyme solutions.

U.S. Lactase Market Trends

The U.S. remains a major center of innovation in the North American lactose-free dairy industry. Established brands such as LACTAID continue to expand the application of lactase across milk, protein milk, creamers, cottage cheese, and ice cream. The introduction of lactose-free creamers illustrates how enzyme technology is moving beyond conventional milk into coffee and other premium dairy consumption occasions. LACTAID specifically uses lactase to break down lactose in its dairy-based products, supporting wider product diversification.

The growth of functional dairy is creating another important avenue for lactase suppliers. fairlife, for example, combines ultra-filtration with lactase enzyme treatment in its milk and high-protein beverage portfolio. Its products demonstrate how lactose reduction can be integrated with high-protein and lower-sugar positioning, increasing the need for enzyme solutions that perform effectively in more complex dairy matrices. These developments are encouraging enzyme manufacturers to focus on flavor neutrality, processing stability, and compatibility with high-protein formulations.

Canada Lactase Market Trends

Canada is experiencing growing demand for inclusive dairy products that address changing dietary preferences without requiring consumers to move away from traditional dairy. Lactalis Canada has expanded its portfolio by developing and launching lactose-free cheese and butter products, highlighting the increasing application of lactase and related dairy-processing technologies beyond fluid milk.

This product expansion is particularly relevant for lactase suppliers because cheese and cultured dairy products often involve more complex processing and fermentation conditions than standard milk. As manufacturers broaden their lactose-free portfolios, demand is likely to increase for enzymes that can deliver reliable performance while maintaining the sensory characteristics, texture, and maturation properties consumers expect from premium dairy products.

Asia Pacific Lactase Market Trends

Asia Pacific is anticipated to be the fastest-growing regional market. Rapid urbanization, changing dietary habits, and rising awareness of lactose intolerance are accelerating interest in lactose-free and digestive-friendly dairy products across major regional economies. The growing popularity of functional nutrition is also encouraging dairy companies to develop products that combine lactose reduction with benefits such as higher protein, lower sugar, or added nutritional ingredients.

China Lactase Market Trends

China represents a significant growth opportunity for lactase applications as dairy producers increasingly combine lactose-free positioning with functional nutrition. Yili’s SHUHUA brand provides a notable example, offering a portfolio of lactose-free milk products based on its lactose hydrolysis technology, including variants designed around low-fat, high-calcium, and other functional positioning.

Such product diversification is increasing demand for lactase technologies capable of supporting different formulations while delivering consistent taste and processing performance. As functional and premium dairy categories expand, enzyme suppliers are likely to benefit from greater demand for customized lactase solutions tailored to specific beverage and dairy applications.

India Lactase Market Trends

India is emerging as an increasingly important market as awareness of lactose intolerance grows alongside demand for convenient and functional dairy products. Amul offers lactose-free milk with less than 0.1% lactose, while its high-protein milk portfolio also uses beta-galactosidase, the enzyme commonly used to hydrolyze lactose.

The presence of specialized brands such as NOLACT further demonstrates the expansion of lactose-free dairy across milk, milkshakes, and other product categories. These developments are creating opportunities for lactase suppliers to support dairy cooperatives and manufacturers with stable enzyme formats suitable for diverse processing environments and expanding distribution networks.

The global lactase market exhibits a moderately concentrated structure, with a mix of enzyme specialists and advanced dairy processors competing on purity, stability, and application versatility. Leading companies are expanding high-efficiency enzyme portfolios tailored for UHT milk, fermented drinks, and lactose-free cheese, supported by deep investments in R&D that improve thermal tolerance and flavor neutrality.

Processing innovations, including immobilized enzyme systems and precision-controlled hydrolysis, are becoming core differentiators for large-scale producers. Certifications such as GMP, FSSC 22000, and clean-label approvals help suppliers secure trust across regulated dairy regions.

Companies are also strengthening technical-support programs, educating customers on optimal enzyme dosage, processing conditions, and sensory outcomes. Growing emphasis on digital documentation, application trials, and co-development projects further defines competitiveness across global supply networks.

Key Industry Developments:

• In April 2026, Kerry opened an expanded biotechnology manufacturing facility in Carrigaline, Ireland, increasing its industrial-scale lactase enzyme production capacity to support growing global demand for lactose-free and sugar-reduced dairy products.